| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.710 | 10.547 | 12.702 | 15.023 | 28.785 | 43.504 | 50.944 | 60.556 | 70.073 |
| Total Income - EUR | - | 3.710 | 10.547 | 12.702 | 15.023 | 28.785 | 43.504 | 50.944 | 60.556 | 70.073 |
| Total Expenses - EUR | - | 244 | 575 | 770 | 635 | 889 | 632 | 898 | 8.556 | 9.652 |
| Gross Profit/Loss - EUR | - | 3.465 | 9.972 | 11.932 | 14.388 | 27.896 | 42.872 | 50.046 | 52.000 | 60.421 |
| Net Profit/Loss - EUR | - | 3.354 | 9.656 | 11.551 | 13.937 | 27.074 | 41.567 | 48.747 | 51.406 | 58.360 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sepsi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 145 | 109 | 75 | 42 | 10 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.426 | 9.774 | 11.630 | 14.063 | 27.395 | 41.973 | 49.334 | 65.816 | 59.672 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 573 | 686 | 964 | 851 | 2.698 | 4.039 | 39.562 | 10.424 | 47.516 |
| Cash | - | 2.853 | 9.088 | 10.666 | 13.212 | 24.697 | 37.934 | 9.772 | 55.392 | 12.156 |
| Shareholders Funds | - | 3.399 | 9.708 | 11.602 | 13.988 | 27.124 | 41.615 | 48.795 | 65.019 | 58.408 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 172 | 185 | 103 | 117 | 286 | 362 | 542 | 838 | 1.299 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sepsi Med Srl